New drug VS-041 aims to ease stiff heart condition
Symptom relief
Recruiting now
This early-stage trial tests the safety of a new drug called VS-041 in 42 adults aged 50 and older who have a type of heart failure where the heart pumps normally but is too stiff (HFpEF). Researchers will monitor side effects and measure changes in blood markers related to heart…
Phase: PHASE1 • Sponsor: Vasa Therapeutics • Aim: Symptom relief
Last updated May 08, 2026 12:04 UTC